Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

Tina Ken Schramm, Gunnar Gislason, Lars Køber, +9

Circulation

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

Gunnar Gislason, Søren Jacobsen, Jeppe Nørgaard Rasmussen, +8

Circulation

Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study

Pernille Buch, Jens Friberg, Henrik Scharling, +2

European Respiratory Journal

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction

Gunnar Gislason, Jeppe Nørgaard Rasmussen, Steen Z. Abildstrøm, +8

European Heart Journal

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure

Gunnar Gislason, Jeppe Nørgaard Rasmussen, Steen Z. Abildstrøm, +12

Archives of Internal Medicine

Rising Rates of Hospital Admissions for Atrial Fibrillation

Jens Friberg, Pernille Buch, Henrik Scharling, +2

Epidemiology

Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes

Gunnar Gislason, Jeppe Nørgaard Rasmussen, Steen Z. Abildstrøm, +10

Circulation

Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002

Pernille Buch, S. Rasmussen, Gunnar Gislason, +7

Heart

The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction: follow-up to 12 years

Pernille Buch, Søren Rasmussen, Steen Z. Abildstrøm, +3

European Heart Journal

Statin use after acute myocardial infarction: a nationwide study in Denmark

Jeppe Nørgaard Rasmussen, Gunnar Gislason, Steen Z. Abildstrøm, +7

British Journal of Clinical Pharmacology